Filing Details
- Accession Number:
- 0001209191-15-006568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-26 18:04:05
- Reporting Period:
- 2015-01-23
- Filing Date:
- 2015-01-26
- Accepted Time:
- 2015-01-26 18:04:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1273636 | Applied Genetic Technologies Corp | AGTC | Biological Products, (No Disgnostic Substances) (2836) | 593553710 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1472131 | L Daniel Menichella | C/O Applied Genetic Technologies Corp. 11801 Research Drive, Suite D Alachua FL 32615 | V.p. & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-23 | 1,996 | $4.90 | 1,996 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-23 | 1,996 | $24.90 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-01-23 | 1,996 | $0.00 | 1,996 | $4.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 115,972 | 2023-09-18 | No | 4 | M | Direct |
Footnotes
- The option, representing a right to purchase a total of 126,968 shares, became exercisable for 25% of the underlying shares on September 18, 2014, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option becoming exercisable for 100% of the underlying shares on the fourth anniversary of the date of grant.
Billionaire Hedge Funds
